Around the Net

Madison Ave. Sharing Drug Makers' Pain

Media companies are feeling their own pain from the COX-2 debacle. Now that Pfizer has suspended its multimillion-dollar consumer advertising program for its COX-2 inhibitor painkiller, Celebrex, and Merck has taken its similar - and similarly advertised - drug, Vioxx, off the market, the prescription drug ad market is not looking nearly as healthy as it seemed earlier this year.

Read the whole story at The New York Times, December 21, 2004 »

Next story loading loading..